CARBAMAZEPINE Side Effects

7022141-5 | Abnormal Behaviour, Agitation, Bipolar Disorder, Delusion, Depression, Dysphoria, Dyspnoea, Dysthymic Disorder
on Sep 16, 2010 Female patient from HUNGARY , 59 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Carbamazepine (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, agitation, bipolar disorder (What is bipolar disorder?), delusion, depression (What is depression?), dysphoria, dyspnoea, dysthymic disorder. Carbamazepine dosage: Unk. During the same period patient was treated with VALPROATE BISMUTH (Unk) (View Valproate Bismuth Review and Valproate Bismuth Label ), LITHIUM (View Lithium Review and Lithium Label ), ARIPIPRAZOLE (30mg, Per Day) (View Aripiprazole Review and Aripiprazole Label ), VENLAFAXINE (75mg,) (View Venlafaxine Review and Venlafaxine Label ). Patient was hospitalized.

7009167-2 | Convulsion, Product Substitution Issue
Patient was taking Carbamazepine (View Usage). Patient had the following side effects: convulsion, product substitution issue on Sep 02, 2010 from UNITED STATES Additional patient health information: Male patient , 27 years of age, weighting 330.7 lb, was diagnosed with epilepsy (What is epilepsy?) and. Carbamazepine dosage: 1200 Mg;qd; Po 800 Mg;qd; Po. During the same period patient was treated with MLULTIVITAMIN (View Mlultivitamin Review and Mlultivitamin Label ).

7006627-5 | Hyponatraemia
Adverse event was reported on Sep 21, 2010 by a Female patient taking Carbamazepine (View Usage) (Dosage: 300 Mg Bid Po) was diagnosed with convulsion and. Location: UNITED STATES , 78 years of age, weighting 110.7 lb, After Carbamazepine was administered, patient had the following side effects: hyponatraemia. Patient was hospitalized.

7004032-9 | Hepatic Adenoma
on Sep 06, 2010 Male patient from UNITED STATES , 22 years of age, was diagnosed with convulsion and was treated with Carbamazepine (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic adenoma. Carbamazepine dosage: . During the same period patient was treated with ETHOSUXIMIDE (View Ethosuximide Review and Ethosuximide Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), VALPROIC ACID SYRUP (View Valproic Acid Syrup Review and Valproic Acid Syrup Label ).


7003974-8 | Hepatic Adenoma
on Sep 06, 2010 Female patient from UNITED STATES , 44 years of age, was diagnosed with convulsion and was treated with Carbamazepine (View Usage). Patient had the following side effects: hepatic adenoma. Carbamazepine dosage: .

6994617-8 | Asterixis
Patient was taking Carbamazepine (View Usage). After Carbamazepine was administered, patient had the following side effects: asterixis on Sep 16, 2010 from UNITED STATES Additional patient health information: Female patient , 72 years of age, weighting 140.0 lb, was diagnosed with neuropathy peripheral and. Carbamazepine dosage: Carbamazepine 200 Mg Bid Po.

6984980-6 | Hepatic Adenoma
Adverse event was reported on Aug 28, 2010 by a Male patient taking Carbamazepine (View Usage) (Dosage: ) was diagnosed with convulsion and. Location: UNITED STATES , 22 years of age, Patient experienced the following unwanted or unexpected effects: hepatic adenoma. During the same period patient was treated with ETHOSUXIMIDE (View Ethosuximide Review and Ethosuximide Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), VALPROIC ACID SYRUP (View Valproic Acid Syrup Review and Valproic Acid Syrup Label ).

6984979-X | Hepatic Adenoma
on Aug 28, 2010 Female patient from UNITED STATES , 44 years of age, was diagnosed with convulsion and was treated with Carbamazepine (View Usage). Patient had the following side effects: hepatic adenoma. Carbamazepine dosage: .

6980529-2 | Hepatic Adenoma
on Sep 03, 2010 Female patient from UNITED STATES , 44 years of age, was treated with Carbamazepine (View Usage). After Carbamazepine was administered, patient had the following side effects: hepatic adenoma. Carbamazepine dosage: .

6973347-2 | Hepatic Adenoma
Patient was taking Carbamazepine (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic adenoma on Sep 01, 2010 from UNITED STATES Additional patient health information: Female patient , 44 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Carbamazepine dosage: .

6973075-3 | Cardiac Failure, Coagulopathy, Dialysis, Eye Disorder, Gastrointestinal Disorder, Heparin-induced Thrombocytopenia, Iliac Artery Occlusion, No Therapeutic Response
Adverse event was reported on Aug 26, 2010 by a Male patient taking Carbamazepine (View Usage) (Dosage: ) was diagnosed with bipolar disorder (What is bipolar disorder?) and. Location: GERMANY , 26 years of age, Patient had the following side effects: cardiac failure, coagulopathy, dialysis (What is dialysis?), eye disorder, gastrointestinal disorder, heparin-induced thrombocytopenia, iliac artery occlusion, no therapeutic response. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), ARGATROBAN (View Argatroban Review and Argatroban Label ). Patient was hospitalized.

6972853-4 |
on Sep 06, 2010 Male patient from SWITZERLAND , child 11 years of age, was treated with Carbamazepine (View Usage). . Carbamazepine dosage: Unk,.

6972363-4 | Erythema, Nikolsky's Sign, Rash Macular, Skin Exfoliation, Toxic Epidermal Necrolysis
on Aug 30, 2010 Male patient from CHINA , 70 years of age, was diagnosed with post herpetic neuralgia and was treated with Carbamazepine (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, nikolsky's sign, rash macular, skin exfoliation, toxic epidermal necrolysis. Carbamazepine dosage: 0.2 G, 3 Times/d. Patient was hospitalized.

6971767-3 | Ataxia, Balance Disorder, Depressed Level Of Consciousness, Headache, Hemiparesis, Hyporeflexia, Nausea, Oculogyric Crisis
Patient was taking Carbamazepine (View Usage). Patient had the following side effects: ataxia (What is ataxia?), balance disorder, depressed level of consciousness, headache (What is headache?), hemiparesis, hyporeflexia, nausea (What is nausea?), oculogyric crisis on Aug 17, 2010 from GERMANY Additional patient health information: Female patient , 24 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Carbamazepine dosage: 2100 Mg;qd ; 600 Mg;bid. During the same period patient was treated with VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), CLOBAZAM (CLOBAZAM) (View Clobazam (clobazam) Review and Clobazam (clobazam) Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ). Patient was hospitalized.

6969134-1 | Eosinophilia, Hepatitis, Pyrexia, Rash Morbilliform
Adverse event was reported on Aug 27, 2010 by a Male patient taking Carbamazepine (View Usage) (Dosage: ) . Location: SINGAPORE , 40 years of age, After Carbamazepine was administered, patient had the following side effects: eosinophilia, hepatitis (What is hepatitis?), pyrexia, rash morbilliform. During the same period patient was treated with CHLORPROMAZINE (View Chlorpromazine Review and Chlorpromazine Label ). Patient was hospitalized.

6966800-9 | Acne, Angina Pectoris, Body Temperature Increased, Chest Pain, Drooling, Dysphagia, Dyspnoea, Headache
on Aug 23, 2010 Male patient from CHINA , 45 years of age, was diagnosed with trigeminal neuralgia (What is trigeminal neuralgia?) and was treated with Carbamazepine (View Usage). Patient experienced the following unwanted or unexpected effects: acne (What is acne?), angina pectoris, body temperature increased, chest pain (What is chest pain?), drooling, dysphagia, dyspnoea, headache (What is headache?). Carbamazepine dosage: 0.1 G, Tid. During the same period patient was treated with CEFOTAXIME SODIUM (4.0 Gm) (View Cefotaxime Sodium Review and Cefotaxime Sodium Label ), DEXAMETHASONE (15 Mg) (View Dexamethasone Review and Dexamethasone Label ), CALCIUM GLUCONATE (10 Ml) (View Calcium Gluconate Review and Calcium Gluconate Label ), CETIRIZINE HCL (10 Mg) (View Cetirizine Hcl Review and Cetirizine Hcl Label ), CALAMINE LOTION (View Calamine Lotion Review and Calamine Lotion Label ), DOBELL'S SOLUTION (View Dobell's Solution Review and Dobell's Solution Label ). Patient was hospitalized.

6966170-6 | Colonoscopy, Diarrhoea, Eosinophilia, Erythema, Hepatic Failure, Hypoxia, Large Intestinal Ulcer, Oedema Peripheral
on Aug 26, 2010 Female patient from JAPAN , 74 years of age, weighting 86.86 lb, was diagnosed with pain in extremity, adenocarcinoma, metastases to bone and was treated with Carbamazepine (View Usage). Patient had the following side effects: colonoscopy (What is colonoscopy?), diarrhoea, eosinophilia, erythema, hepatic failure, hypoxia, large intestinal ulcer, oedema peripheral. Carbamazepine dosage: . During the same period patient was treated with MEXILETINE (NGX) (View Mexiletine (ngx) Review and Mexiletine (ngx) Label ), GEFITINIB (Unk) (View Gefitinib Review and Gefitinib Label ). Patient was hospitalized.

6961229-1 | Arrhythmia, Atrioventricular Block, Cardiac Failure, Cardiac Index Increased, Cardiac Pacemaker Insertion, Cardiomyopathy Alcoholic, Conduction Disorder, Congestive Cardiomyopathy
Patient was taking Carbamazepine (View Usage). After Carbamazepine was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), atrioventricular block, cardiac failure, cardiac index increased, cardiac pacemaker insertion, cardiomyopathy alcoholic, conduction disorder, congestive cardiomyopathy on May 19, 2010 from BRAZIL Additional patient health information: Male patient , 20 years of age, was diagnosed with impulsive behaviour and. Carbamazepine dosage: 800 Mg Per Day. During the same period patient was treated with HALOPERIDOL (10 Mg Per Day) (View Haloperidol Review and Haloperidol Label ), LORAZEPAM (2 Mg At Night) (View Lorazepam Review and Lorazepam Label ), PIMOZIDE (4 Mg, Tid) (View Pimozide Review and Pimozide Label ). Patient was hospitalized.

6961083-8 | Abortion Induced
Adverse event was reported on Aug 30, 2010 by a Female patient taking Carbamazepine (View Usage) (Dosage: ) was diagnosed with epilepsy (What is epilepsy?) and. Location: HUNGARY , weighting 163.1 lb, Patient experienced the following unwanted or unexpected effects: abortion induced. During the same period patient was treated with OVIDON (View Ovidon Review and Ovidon Label ). Patient was hospitalized.

6956043-7 | Hepatic Adenoma, Surgery
on Aug 19, 2010 Male patient from UNITED STATES , 22 years of age, was diagnosed with convulsion and was treated with Carbamazepine (View Usage). Patient had the following side effects: hepatic adenoma, surgery (What is surgery?). Carbamazepine dosage: . During the same period patient was treated with VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), ETHOSUXIMIDE (View Ethosuximide Review and Ethosuximide Label ), PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ).

6955557-3 | Asthenia, Depression, Dysphagia, Epistaxis, Malaise, Ocular Hyperaemia, Oral Pain, Pyrexia
on Aug 26, 2010 Female patient from UNITED STATES , 55 years of age, weighting 189.0 lb, was diagnosed with trigeminal neuralgia (What is trigeminal neuralgia?) and was treated with Carbamazepine (View Usage). After Carbamazepine was administered, patient had the following side effects: asthenia, depression (What is depression?), dysphagia, epistaxis, malaise, ocular hyperaemia, oral pain, pyrexia. Carbamazepine dosage: 200mg Three Times A Day Po. Patient was hospitalized.

6945984-2 | Arrhythmia, Coma, Electrocardiogram Qt Prolonged, Hepatic Steatosis, Liver Disorder
Patient was taking Carbamazepine (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), coma, electrocardiogram qt prolonged, hepatic steatosis, liver disorder on Aug 13, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 42 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and. Carbamazepine dosage: . During the same period patient was treated with OLANZAPINE (View Olanzapine Review and Olanzapine Label ), ZOPICLONE (ZOPICLONE) (View Zopiclone (zopiclone) Review and Zopiclone (zopiclone) Label ), CITALOPRAM (CON.) (View Citalopram (con.) Review and Citalopram (con.) Label ), SIMVASTATIN (CON.) (View Simvastatin (con.) Review and Simvastatin (con.) Label ), FEXOFENADINE (CON.) (View Fexofenadine (con.) Review and Fexofenadine (con.) Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), SODIUM (CON.) (View Sodium (con.) Review and Sodium (con.) Label ), OMEPRAZOLE (CON.) (View Omeprazole (con.) Review and Omeprazole (con.) Label ).

6943298-8 | Abortion Induced
Adverse event was reported on Aug 19, 2010 by a Female patient taking Carbamazepine (View Usage) (Dosage: ) was diagnosed with epilepsy (What is epilepsy?) and. Location: HUNGARY , weighting 163.1 lb, Patient had the following side effects: abortion induced. During the same period patient was treated with OVIDON (View Ovidon Review and Ovidon Label ).

6935039-5 | Abortion Spontaneous
on Aug 11, 2010 Female patient from NORWAY , 19 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Carbamazepine (View Usage). After Carbamazepine was administered, patient had the following side effects: abortion spontaneous. Carbamazepine dosage: Unk. During the same period patient was treated with WARFARIN (12.5-15mg/day (target Inr 3.0-4.5)) (View Warfarin Review and Warfarin Label ).

6926217-X | Asthma, Stevens-johnson Syndrome
on Aug 13, 2010 Female patient from UNITED STATES , 48 years of age, weighting 154.3 lb, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Carbamazepine (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), stevens-johnson syndrome. Carbamazepine dosage: 200mg Twice Daily Po. During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ACETAMINOPHEN AND HYDROCODONE BITARTRATE (View Acetaminophen And Hydrocodone Bitartrate Review and Acetaminophen And Hydrocodone Bitartrate Label ), ACTOS (View Actos Review and Actos Label ), AVAPRO (View Avapro Review and Avapro Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ). Patient was hospitalized.

6926179-5 | Convulsion, Product Substitution Issue, Treatment Failure
Patient was taking Carbamazepine (View Usage). Patient had the following side effects: convulsion, product substitution issue, treatment failure on Aug 13, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 263.7 lb, was diagnosed with temporal lobe epilepsy and. Carbamazepine dosage: 200mg Twice Daily Oral (047) (prior To 1992).

6925283-5 | Condition Aggravated, Encephalopathy, Epilepsy
Adverse event was reported on Jul 26, 2010 by a Female patient taking Carbamazepine (View Usage) (Dosage: 15 Mg/kg (15 Mg/kg, 1 In 1 D), Oral) . Location: CHINA , child 2. years of age, After Carbamazepine was administered, patient had the following side effects: condition aggravated, encephalopathy, epilepsy (What is epilepsy?).

6925272-0 | Condition Aggravated, Epilepsy
on Jul 26, 2010 Male patient from CHINA , child 3 years of age, was treated with Carbamazepine (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, epilepsy (What is epilepsy?). Carbamazepine dosage: 20 Mg/kg (20 Mg/kg, 1 In 1 D).

6925004-6 | Urinary Incontinence
on Jul 29, 2010 Female patient from UNITED KINGDOM , 44 years of age, was diagnosed with epilepsy (What is epilepsy?), depression (What is depression?) and was treated with Carbamazepine (View Usage). Patient had the following side effects: urinary incontinence (What is urinary incontinence?). Carbamazepine dosage: 400 Mg;bid. During the same period patient was treated with MIRTAZAPINE (45 Mg;qd) (View Mirtazapine Review and Mirtazapine Label ), DOLMATIL (SULPIRIDE) (600 Mg;bid;po) (View Dolmatil (sulpiride) Review and Dolmatil (sulpiride) Label ).

6924551-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Asthenia, Blister, Conjunctival Hyperaemia, Discomfort, Erythema, Eye Discharge, Feeling Cold
Patient was taking Carbamazepine (View Usage). After Carbamazepine was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, blister, conjunctival hyperaemia, discomfort, erythema, eye discharge, feeling cold on Aug 05, 2010 from CHINA Additional patient health information: Female patient , 36 years of age, was diagnosed with herpes zoster and. Carbamazepine dosage: Unk,unk. Patient was hospitalized.

6918162-0 | Anxiety, Aura, Fatigue, Grand Mal Convulsion, Impaired Driving Ability, Product Substitution Issue, Somnolence, Speech Disorder
Adverse event was reported on Jul 20, 2010 by a Male patient taking Carbamazepine (View Usage) (Dosage: 600 Mg; Bid; Po, 300 Mg; Qd; Po) was diagnosed with epilepsy (What is epilepsy?) and. Location: UNITED STATES , weighting 223.0 lb, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), aura, fatigue, grand mal convulsion, impaired driving ability, product substitution issue, somnolence, speech disorder. During the same period patient was treated with LIPOFEN (FENOFIBRATE) (View Lipofen (fenofibrate) Review and Lipofen (fenofibrate) Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ARTHROTEC (DICLOFENAC AND MISOPROSTOL) (View Arthrotec (diclofenac And Misoprostol) Review and Arthrotec (diclofenac And Misoprostol) Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LEVETIRACETAM (View Levetiracetam Review and Levetiracetam Label ). Patient was hospitalized.

6905248-X | Urinary Incontinence
on Jul 30, 2010 Female patient from UNITED KINGDOM , 44 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Carbamazepine (View Usage). Patient had the following side effects: urinary incontinence (What is urinary incontinence?). Carbamazepine dosage: . During the same period patient was treated with MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), SULPIRIDE (View Sulpiride Review and Sulpiride Label ).

6901046-1 | Fanconi Syndrome
on Jul 16, 2010 Female patient from JAPAN , 15 years of age, was treated with Carbamazepine (View Usage). After Carbamazepine was administered, patient had the following side effects: fanconi syndrome. Carbamazepine dosage: 10 Mg/kg (10 Mg/kg, 1 In 1 D). During the same period patient was treated with VALPROIC ACID (25 Mg/kg (25 Mg/kg, 1 In 1 D)) (View Valproic Acid Review and Valproic Acid Label ), CLOBAZAM (0.7 Mg/kg (0.7 Mg/kg, 1 In 1 D)) (View Clobazam Review and Clobazam Label ).

6894393-3 | Atrioventricular Block Complete, Cardiac Failure, Cardiomyopathy Alcoholic, Congestive Cardiomyopathy, Ejection Fraction Decreased, Electrocardiogram Qrs Complex Abnormal, Electrocardiogram Qt Prolonged, Syncope
Patient was taking Carbamazepine (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block complete, cardiac failure, cardiomyopathy alcoholic, congestive cardiomyopathy, ejection fraction decreased, electrocardiogram qrs complex abnormal, electrocardiogram qt prolonged, syncope on Jul 12, 2010 from BRAZIL Additional patient health information: Male patient , 20 years of age, was diagnosed with schizophrenia and. Carbamazepine dosage: 800 Mg (800 Mg,1 In 1 D). During the same period patient was treated with HALOPERIDOL (10 Mg (10 Mg,1 In 1 D)) (View Haloperidol Review and Haloperidol Label ), LORAZEPAM (2 Mg (2 Mg,1 In 1d)) (View Lorazepam Review and Lorazepam Label ), PIMOZIDE (12 Mg (4 Mg,3 In 1 D)) (View Pimozide Review and Pimozide Label ). Patient was hospitalized.

6887798-8 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatinine Increased, Blood Urea Increased, Hepatitis Cholestatic, Loss Of Consciousness, Lymphocyte Transformation Test Positive, Renal Tubular Necrosis
Adverse event was reported on Jul 16, 2010 by a Male patient taking Carbamazepine (View Usage) (Dosage: 200 Mg Per Day) was diagnosed with epilepsy (What is epilepsy?) and. Location: JAPAN , 65 years of age, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, blood urea increased, hepatitis cholestatic, loss of consciousness, lymphocyte transformation test positive, renal tubular necrosis. Patient was hospitalized.

6878845-8 | Blood Cholesterol Increased, Blood Triglycerides Increased, Convulsion, Dyslipidaemia, Hepatic Steatosis, Hyponatraemia, Obesity, Pancreas Lipomatosis, Splenomegaly
on Jul 12, 2010 Male patient from GERMANY , weighting 264.6 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Carbamazepine (View Usage). After Carbamazepine was administered, patient had the following side effects: blood cholesterol increased, blood triglycerides increased, convulsion, dyslipidaemia, hepatic steatosis, hyponatraemia, obesity (What is obesity?), pancreas lipomatosis, splenomegaly. Carbamazepine dosage: 0.5-0-0 Df/daily. During the same period patient was treated with LAMOTRIGINE (200 Mg, (0.5-0-0.5 Df Daily)) (View Lamotrigine Review and Lamotrigine Label ). Patient was hospitalized.

6877873-6 | Myocarditis
on Jul 16, 2010 Female patient from GERMANY , 46 years of age, was diagnosed with neuralgia and was treated with Carbamazepine (View Usage). Patient experienced the following unwanted or unexpected effects: myocarditis. Carbamazepine dosage: . During the same period patient was treated with LYRICA (50 Mg In The Morning And 75 Mg In The Evening) (View Lyrica Review and Lyrica Label ).

6876585-2 | Anxiety, Aura, Grand Mal Convulsion, Impaired Driving Ability, Somnolence, Speech Disorder, Tablet Issue
Patient was taking Carbamazepine (View Usage). Patient had the following side effects: anxiety (What is anxiety?), aura, grand mal convulsion, impaired driving ability, somnolence, speech disorder, tablet issue on Jul 06, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 223.0 lb, was diagnosed with epilepsy (What is epilepsy?) and. Carbamazepine dosage: 600 Mg;bid;po ; 300 Mg;qd;po. During the same period patient was treated with LIPOFEN (FENOFIBRATE) (View Lipofen (fenofibrate) Review and Lipofen (fenofibrate) Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ARTHROTEC (DICLOFENAC AND MISOPROSTOL) (View Arthrotec (diclofenac And Misoprostol) Review and Arthrotec (diclofenac And Misoprostol) Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LEVETIRACETAM (View Levetiracetam Review and Levetiracetam Label ). Patient was hospitalized and became disabled.

6874606-4 | Aggression, Alcohol Use, Antisocial Behaviour, Anxiety, Body Temperature Increased, Cholinergic Syndrome, Cognitive Disorder, Depression, Disease Recurrence
Adverse event was reported on Jul 13, 2010 by a Male patient taking Carbamazepine (View Usage) (Dosage: 1200 Mg; Qd;) was diagnosed with schizophrenia and. Location: , 17 years of age, After Carbamazepine was administered, patient had the following side effects: aggression, alcohol use, antisocial behaviour, anxiety (What is anxiety?), body temperature increased, cholinergic syndrome, cognitive disorder, depression (What is depression?), disease recurrence. During the same period patient was treated with AMISULPRIDE (AMISULPRIDE) (View Amisulpride (amisulpride) Review and Amisulpride (amisulpride) Label ), CLOZARIL (View Clozaril Review and Clozaril Label ), ZUCLOPENTHIXOL (View Zuclopenthixol Review and Zuclopenthixol Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), DEPIXOL (View Depixol Review and Depixol Label ), PROCYCLIDINE HYDROCHLORIDE 2MG TAB (View Procyclidine Hydrochloride 2mg Tab Review and Procyclidine Hydrochloride 2mg Tab Label ), TRIFLUOPERAZINE (View Trifluoperazine Review and Trifluoperazine Label ). Patient was hospitalized.

6868684-6 | Neutropenia
on Jul 21, 2010 Male patient from UNITED STATES , 45 years of age, weighting 200.0 lb, was treated with Carbamazepine (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenia. Carbamazepine dosage: 600mg Daily Po.

6862329-7 | Abnormal Behaviour, Anomaly Of External Ear Congenital, Antisocial Behaviour, Autism Spectrum Disorder, Borderline Personality Disorder, Cognitive Disorder, Communication Disorder, Decreased Eye Contact, Distractibility
on Jul 09, 2010 Male patient from NETHERLANDS , 40 years of age, was treated with Carbamazepine (View Usage). Patient had the following side effects: abnormal behaviour, anomaly of external ear congenital, antisocial behaviour, autism spectrum disorder, borderline personality disorder, cognitive disorder, communication disorder, decreased eye contact, distractibility. Carbamazepine dosage: . During the same period patient was treated with PHENYTOIN (View Phenytoin Review and Phenytoin Label ), PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ).

6860274-4 | Hepatitis Cholestatic, Renal Tubular Necrosis
Patient was taking Carbamazepine (View Usage). After Carbamazepine was administered, patient had the following side effects: hepatitis cholestatic, renal tubular necrosis on Jul 09, 2010 from JAPAN Additional patient health information: Male patient , 65 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Carbamazepine dosage: 200 Mg. Patient was hospitalized.

6860222-7 | Dermatitis Contact, Erythema Multiforme
Adverse event was reported on Jul 19, 2010 by a Female patient taking Carbamazepine (View Usage) (Dosage: 200 Mg Bid) was diagnosed with convulsion and. Location: UNITED STATES , 43 years of age, weighting 149.9 lb, Patient experienced the following unwanted or unexpected effects: dermatitis contact, erythema multiforme.

6856840-2 | Abnormal Behaviour, Aggression, Antisocial Behaviour, Anxiety, Cholinergic Syndrome, Cognitive Disorder, Delusion, Depression, Echolalia
on Jul 12, 2010 Male patient from UNITED KINGDOM , 17 years of age, was diagnosed with schizophrenia and was treated with Carbamazepine (View Usage). Patient had the following side effects: abnormal behaviour, aggression, antisocial behaviour, anxiety (What is anxiety?), cholinergic syndrome, cognitive disorder, delusion, depression (What is depression?), echolalia. Carbamazepine dosage: . During the same period patient was treated with AMISULPRIDE (View Amisulpride Review and Amisulpride Label ), CLOZAPINE (View Clozapine Review and Clozapine Label ). Patient was hospitalized.

6856636-1 | Convulsion, Fall, Feeling Cold, Inflammation, Nausea
on Jul 16, 2010 Female patient from MEXICO , 53 years of age, weighting 112.4 lb, was treated with Carbamazepine (View Usage). After Carbamazepine was administered, patient had the following side effects: convulsion, fall (What is fall?), feeling cold, inflammation, nausea (What is nausea?). Carbamazepine dosage: . During the same period patient was treated with NIMESULIDA (View Nimesulida Review and Nimesulida Label ). Patient was hospitalized.

6839338-7 | Blister, Flushing, Lip Swelling, Scab, Skin Exfoliation
Patient was taking Carbamazepine (View Usage). Patient experienced the following unwanted or unexpected effects: blister, flushing, lip swelling, scab (What is scab?), skin exfoliation on Jul 05, 2010 from CHINA Additional patient health information: Male patient , 42 years of age, was diagnosed with trigeminal neuralgia (What is trigeminal neuralgia?) and. Carbamazepine dosage: 100 Mg, Bid. Patient was hospitalized.

6822098-3 | Blood Sodium Decreased, Confusional State, Convulsion, Delusion, Social Problem, Treatment Noncompliance
Adverse event was reported on Jun 21, 2010 by a Female patient taking Carbamazepine (View Usage) (Dosage: 700 Mg; Po) was diagnosed with epilepsy (What is epilepsy?), depressed mood and. Location: DENMARK , 39 years of age, Patient had the following side effects: blood sodium decreased, confusional state, convulsion, delusion, social problem, treatment noncompliance. During the same period patient was treated with CITALOPRAM HYDROBROMIDE (10 Mg;po) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), ACETAMINOPHEN AND CODEINE PHOSPHATE (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ), DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ), BECLOMETHASONE DIPROPIONATE (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ), SALBUTAMOL (View Salbutamol Review and Salbutamol Label ). Patient was hospitalized.

6819521-7 | Blood Disorder
on Jun 25, 2010 Female patient from UNITED KINGDOM , 75 years of age, was diagnosed with neuralgia and was treated with Carbamazepine (View Usage). After Carbamazepine was administered, patient had the following side effects: blood disorder. Carbamazepine dosage: 100 Mg, Qd. During the same period patient was treated with DIHYDROCODEINE BITARTRATE INJ (View Dihydrocodeine Bitartrate Inj Review and Dihydrocodeine Bitartrate Inj Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), QUININE (View Quinine Review and Quinine Label ), RISEDRONIC ACID (View Risedronic Acid Review and Risedronic Acid Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ).

6809539-2 | Blood Lactic Acid Increased, Heart Rate Increased, Hyporeflexia, Hypotonia, Melas Syndrome, Metabolic Acidosis, Mitochondrial Cytopathy, Mydriasis
on Jun 17, 2010 Female patient from UNITED STATES , 29 years of age, was diagnosed with convulsion and was treated with Carbamazepine (View Usage). Patient experienced the following unwanted or unexpected effects: blood lactic acid increased, heart rate increased, hyporeflexia, hypotonia, melas syndrome, metabolic acidosis, mitochondrial cytopathy, mydriasis. Carbamazepine dosage: 600 Mg/day.

6809303-4 | Alanine Aminotransferase Increased, Blood Sodium Decreased, Chills, Disorientation, Face Oedema, Headache, Hypotension, Meningitis
Patient was taking Carbamazepine (View Usage). Patient had the following side effects: alanine aminotransferase increased, blood sodium decreased, chills, disorientation, face oedema, headache (What is headache?), hypotension, meningitis (What is meningitis?) on Jun 15, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 48 years of age, was diagnosed with myoclonic epilepsy and. Carbamazepine dosage: 200 Mg; Qam. During the same period patient was treated with LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), PREV MEDS (View Prev Meds Review and Prev Meds Label ). Patient was hospitalized.